GDS Wealth Management

Position in ABT — Abbott Laboratories

CIK 1940869 FLOWER MOUND, TX

Position in ABT

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$420,035

-$60,768 QoQ

Shares Held

4,629

-1.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#2,034

of 2,959 holders

Holding Since

Dec 2021

19 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

GDS Wealth Management holds $69,468,212 across 5 Medical Devices names. ABT ranks #5 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EW	Edwards Lifesciences Corp	266,372	$24,096,011
2	DXCM	Dexcom Inc	285,219	$19,209,499
3	STE	STERIS plc	83,846	$17,655,452
4	PODD	Insulet Corp	53,118	$8,087,215
5	ABT	Abbott Laboratories This page	4,629	$420,035

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$420,035	4,629	-1.2%	Shares	Sole	2026-08-13
2026-03-31	$480,803	4,683	+7.2%	Shares	Sole	2026-04-27
2025-12-31	$547,517	4,370	+1.1%	Shares	Sole	2026-02-02
2025-09-30	$578,888	4,322	+0.9%	Shares	Sole	2025-10-31
2025-06-30	$582,394	4,282	+4.7%	Shares	Sole	2025-08-12
2025-03-31	$542,538	4,090	-1.4%	Shares	Sole	2025-05-14
2024-12-31	$469,293	4,149	-0.3%	Shares	Sole	2025-01-24
2024-09-30	$474,395	4,161	-1.2%	Shares	Sole	2024-11-04
2024-06-30	$437,668	4,212	-4.9%	Shares	Sole	2024-08-09
2024-03-31	$503,627	4,431	-3.9%	Shares	Sole	2024-04-24
2023-12-31	$507,312	4,609	+0.8%	Shares	Sole	2024-02-07
2023-09-30	$442,701	4,571	-5.0%	Shares	Sole	2023-10-19
2023-06-30	$524,604	4,812	-0.3%	Shares	Sole	2023-07-27
2023-03-31	$488,579	4,825	+17.5%	Shares	Sole	2023-05-10
2022-12-31	$451,017	4,108	-0.8%	Shares	Sole	2023-01-26
2022-09-30	$400,876	4,143	+3.2%	Shares	Sole	2022-10-20
2022-06-30	$436,229	4,015	0.0%	Shares	Sole	2022-08-05
2022-03-31	$475,215	4,015	-1.7%	Shares	Sole	2022-08-05
2021-12-31	$574,641	4,083	—	Shares	Sole	2022-08-05
No filing history on record for this holder in this stock.